Manchester Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Manchester Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$949	Hold	28	–	–	﹤0.01%	1177
2026 Q1	$844	Hold	28	–	–	﹤0.01%	1163
2025 Q4	$874	Buy	+28	New	+$690	﹤0.01%	1159
2019 Q3	–	Sell	-116	Closed	-$1K	–	552
2019 Q2	$1K	Hold	116	–	–	﹤0.01%	550
2019 Q1	$2K	Hold	116	–	–	﹤0.01%	629
2018 Q4	$3K	Hold	116	–	–	﹤0.01%	501
2018 Q3	$2K	Hold	116	–	–	﹤0.01%	517
2018 Q2	$3K	Hold	116	–	–	﹤0.01%	515
2018 Q1	$2K	Hold	116	–	–	﹤0.01%	542
2017 Q4	$2K	Hold	116	–	–	﹤0.01%	485
2017 Q3	$2K	Hold	116	–	–	﹤0.01%	472
2017 Q2	$4K	Hold	116	–	–	﹤0.01%	459
2017 Q1	$4K	Hold	116	–	–	﹤0.01%	474
2016 Q4	$4K	Sell	116 -260	-69%	-$10.4K	﹤0.01%	472
2016 Q3	$17K	Hold	376	–	–	﹤0.01%	432
2016 Q2	$19K	Hold	376	–	–	﹤0.01%	444
2016 Q1	$20K	Hold	376	–	–	﹤0.01%	500
2015 Q4	$25K	Hold	376	–	–	﹤0.01%	551
2015 Q3	$21K	Hold	376	–	–	﹤0.01%	542
2015 Q2	$22K	Hold	376	–	–	﹤0.01%	471
2015 Q1	$23K	Sell	376 -1,183	-76%	-$68.8K	﹤0.01%	453
2014 Q4	$90K	Sell	1,559 -468	-23%	-$26.1K	0.01%	575
2014 Q3	$109K	Buy	2,027 +569	+39%	+$30.1K	0.01%	538
2014 Q2	$76K	Buy	1,458 +1,082	+288%	+$55.3K	0.01%	623
2014 Q1	$20K	Hold	376	–	–	﹤0.01%	764
2013 Q4	$15K	Hold	376	–	–	﹤0.01%	753
2013 Q3	$14K	Hold	376	–	–	﹤0.01%	787
2013 Q2	$15K	Buy	+376	New	+$14.6K	﹤0.01%	786

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Manchester Capital Management's TEVA Position: Q2 2026 in Review

Manchester Capital Management held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 28 shares worth $949. The position accounts for ﹤0.01% of the portfolio, ranked #1177.

Manchester Capital Management first reported a position in TEVA in Q2 2013 and has held it in 28 quarters since. The position peaked at $109K in Q3 2014. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Manchester Capital Management held 28 shares of Teva Pharmaceuticals worth $949 as of Q2 2026.
Manchester Capital Management left its Teva Pharmaceuticals share count unchanged in Q2 2026.
Teva Pharmaceuticals made up ﹤0.01% of Manchester Capital Management's portfolio in Q2 2026, its #1177 holding.
Manchester Capital Management first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 28 quarters since.
Manchester Capital Management's Teva Pharmaceuticals position peaked at $109K in Q3 2014.
672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Manchester Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.